High grade glioma: Imaging combined with pathological grade defines management and predicts prognosis

• Published in: Radiotherapy and oncology Vol. 85; no. 3; pp. 371 - 378
• Main Authors: Burnet, Neil G, Lynch, Andrew G, Jefferies, Sarah J, Price, Stephen J, Jones, Phil H, Antoun, Nagui M, Xuereb, John H, Pohl, Ute
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier Ireland Ltd 01.12.2007
• Subjects: Brain Neoplasms - diagnostic imaging; Brain Neoplasms - mortality; Brain Neoplasms - pathology; Glioblastoma - diagnostic imaging; Glioblastoma - pathology; Glioma; Glioma - diagnostic imaging; Glioma - mortality; Glioma - pathology; Hematology, Oncology and Palliative Medicine; High grade; Humans; Imaging; Pathology; Prognosis; Proportional Hazards Models; Radiography; Pathology; Prognosis; Glioma; Imaging; High grade
• ISSN: 0167-8140; 1879-0887
• DOI: 10.1016/j.radonc.2007.10.008

Abstract Introduction There is ambiguity in pathological grading of high grade gliomas within the WHO 2000 classification, especially those with predominant oligodendroglial differentiation. Patients and methods All adult high grade gliomas treated radically, 1996–2005, were assessed. Cases in which pathology was grade III but radiology suggested glioblastoma (GBM) were classified as ‘grade III/IV’; their pathology was reviewed. Results Data from 245 patients (52 grade III, 18 grade III/IV, 175 GBM) were analysed using a Cox Proportional Hazards model. On pathology review, features suggestive of more aggressive behaviour were found in all 18 grade III/IV tumours. Oligodendroglial components with both necrosis and microvascular proliferation were present in 7. MIB-1 counts for the last 8 were all above 14%, mean 27%. Median survivals were: grade III 34 months, grade III/IV 10 months, GBM 11 months. Survival was not significantly different between grade III/IV and GBM. Patients with grade III/IV tumours had significantly worse outcome than grade III, with a hazard of death 3.7 times higher. Conclusions The results highlight the current inconsistency in pathological grading of high grade tumours, especially those with oligodendroglial elements. Patients with histological grade III tumours but radiological appearances suggestive of GBM should be managed as glioblastoma.